Melissa Morandi
Corporate Officer/Principal bei Parenteral Drug Association
Profil
Melissa Morandi is currently the Director-West Coast Chapter at the Parenteral Drug Association.
She previously worked as the Director of Quality Assurance & Compliance at Biogen, Inc. from 2002 to 2004.
Melissa also held positions as a Quality Assurance Auditor at Amgen, Inc., Senior Manager of Quality Assurance at Genentech, Inc., Vice President of Quality Assurance at Anesiva, Inc. from 2004 to 2013, and Vice President of Quality at Acceleron Pharma, Inc. Melissa has a graduate degree from California State University-Northridge and an undergraduate degree from the University of California, Santa Barbara.
Aktive Positionen von Melissa Morandi
| Unternehmen | Position | Beginn |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Melissa Morandi
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Compliance Officer | 01.03.2004 |
| AMGEN INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Melissa Morandi
| University of California, Santa Barbara | Undergraduate Degree |
| California State University-Northridge | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Parenteral Drug Association |
